Skip to content
OpenCapital
Get started

Nautilus Biotechnology, Inc. NAUT Q1 2026 earnings

Reported April 28, 2026 · Before market open

EPS-$0.12Beat by $0.02
Revenue estimate$250.0K
EPS estimate-$0.15

Next report

Oct 27, 2026 (in 3 months)
Revenue estimate$200.0K
EPS estimate-$0.14

Versus estimates

Revenue

Q2 2026$190.0KBeat by $90.0K

Diluted EPS

Q2 2026-$0.11Beat by $0.03
Q1 2026-$0.12Beat by $0.02
Q4 2025-$0.11Beat by $0.03Q3 2025-$0.11Beat by $0.04Q2 2025-$0.12Beat by $0.04Q1 2025-$0.13Beat by $0.01

Ask the moment Nautilus Biotechnology, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Nautilus Biotechnology, Inc. report Q1 2026 earnings?
Nautilus Biotechnology, Inc. (NAUT) reported Q1 2026 earnings on April 28, 2026 before market open.
What were Nautilus Biotechnology, Inc.'s Q1 2026 revenue and EPS?
Nautilus Biotechnology, Inc. reported eps of $-0.12 for Q1 2026.
Did Nautilus Biotechnology, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.14 by $0.02.
How did Nautilus Biotechnology, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 7.7% from $-0.13.
Where can I find Nautilus Biotechnology, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001808805-26-000015) and the 10-Q periodic report (0001808805-26-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.